FREE SHIPPING ON ORDERS OVER $150

glutathione concentration in liver diseases and hepatotoxicity Frontiers | Glutathione: Pharmacological aspects

$24.29

Quantity
- +
Description

Taguchi K, Yamamoto M (2020) The KEAP1-NRF2 system as a molecular target of cancer treatment

glutathione concentration in liver diseases and hepatotoxicity Frontiers | Glutathione: Pharmacological aspects

Business Type Exporter, Manufacturer, Supplier, Trading Company Employee Count 5 Establishment 2025 Working Days To GST NO 27AAKCN5791J1ZS Payment Mode Online Payments (NEFT/RTGS/IMPS), Cheque/DD Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27AAKCN5791J1ZS Trusted Seller Nagpur, Maharashtra Manager Mr Devansh Agrawal Members since 1 Years Address Block No-W/39, Transport Nagar, Nagpur, Maharashtra, 440008, India Report incorrect details

glutathione concentration in liver diseases and hepatotoxicity Frontiers | Glutathione: Pharmacological aspects

Esposito, P

glutathione concentration in liver diseases and hepatotoxicity Frontiers | Glutathione: Pharmacological aspects

Semax & Selank : Neuropeptides used for cognitive function and anxiety management

glutathione concentration in liver diseases and hepatotoxicity Frontiers | Glutathione: Pharmacological aspects

Step 3 - Evaluate Safety and Transparency Peptides vary widely in quality

glutathione concentration in liver diseases and hepatotoxicity Frontiers | Glutathione: Pharmacological aspects

After the culture medium were replaced with fresh medium, the cells were exposed to 6-OHDA (1050 M for neuronal cultures, 50150 M for neuron-astrocyte co-cultures) for 24 h

glutathione concentration in liver diseases and hepatotoxicity Frontiers | Glutathione: Pharmacological aspects

You may also like

recommand products